Search results
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 16 hours agoWhat was supposed to be a groundbreaking step in mental health treatment became a devastating rebuke...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News via Yahoo News· 22 hours agoAn FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared...
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 16 hours agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
WUSF 89.7· 24 hours agoThe psychedelic drug MDMA is near the end of a decades-long effort to enter mainstream medicine but...
Opinion | Was the FDA Panel Right to Recommend Against MDMA Approval?
MedPage Today· 3 days agoIn the past few years, there has been a resurgence in interest in psychedelic treatments -- for...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 day agoHigh hopes that psychedelic medicines were finally on the pathway to regulation were dashed last...
Felon arrested with stolen gun in Kinston drug bust, faces multiple charges
News Channel 12 New Bern· 20 hours agoA Kinston man was arrested following a drug investigation regarding the distribution of cocaine and ...
What is MDMA? | National Institute on Drug Abuse
Mountain View Telegraph· 1 day agoMDMA is a synthetic drug that acts as a stimulant and hallucinogen.15–17 It produces an energizing effect, distortions in time and perception, and enhanced enjoyment from ...
MDMA, Juul and a cardiovascular disease study. 3 health stories you may have missed — and why they...
Yahoo Life Style via AOL· 6 days ago...Justich explores whether this is a wellness trend worth getting chilly for Good news: You don’t...
MDMA-maker failed its FDA hearing — and its PTSD patients
The Eagle-Tribune· 6 days agoThis week, the Food and Drug Administration’s expert advisers sent a strong message that Lykos...